Showing results (631-640 of 786) with videos related to
Sort By:
Pageof 79
In Silico Pharmacology|June 28, 2017
Revealing the potency of Annona muricata leaves extract as FOXO1 inhibitor for diabetes mellitus treatment through computational studyDini Sri Damayanti, Didik Huswo Utomo, Chandra KusumaIn Silico Pharmacology|July 2, 2017
Molecular docking studies on thirteen fluoroquinolines with human topoisomerase II a and bAshwini Khanderao Jadhav, Sankunny Mohan KaruppayilIn Silico Pharmacology|December 16, 2014
New measurement criteria for studying alcohol drinking and relapse in rodentsLilian Villarín Pildaín, Valentina Vengeliene, Franziska MatthäusIn Silico Pharmacology|December 16, 2014
Convergent functional genomics in addiction research - a translational approach to study candidate genes and gene networksRainer SpanagelIn Silico Pharmacology|December 16, 2014
The Camerino symposium series (1978-2013): a privileged observatory of receptorology developmentMario Giannella, Piero AngeliIn Silico Pharmacology|July 21, 2017
QSAR modeling, docking and ADMET studies for exploration of potential anti-malarial compounds against Plasmodium falciparumTabish QidwaiIn Silico Pharmacology|September 29, 2017
Xeronine structure and function: computational comparative mastery of its mysteryDavid Morakinyo Sanni, Toluwase Hezekiah Fatoki, Ayodele Oluseyi Kolawole, et al.In Silico Pharmacology|January 9, 2018
Impact of protein-ligand solvation and desolvation on transition state thermodynamic properties of adenosine A2A ligand binding kineticsGiuseppe Deganutti, Andrei Zhukov, Francesca Deflorian, et al.In Silico Pharmacology|November 4, 2017
Antiquorum sensing activity of silver nanoparticles in P. aeruginosa: an in silico studySyed Ghazanfar Ali, Mohammad Azam Ansari, Qazi Mohd Sajid Jamal, et al.In Silico Pharmacology|January 5, 2019
High throughput screening against pantothenate synthetase identifies amide inhibitors against Mycobacterium tuberculosis and Staphylococcus aureusSayantan Pradhan, Chittaranjan SinhaPageof 79